| 44.92 Delayed Data As of Jun 26 |  -0.85 / -1.86%Today’s Change | 44.30 Today|||52-Week Range 63.69 | -13.58% Year-to-Date |
| Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries,... Jun 26 / GuruFocus NewsGURU - Paid Partner Content | AbbVie + Allergan: Where Are The Synergies? Jun 25 / Zacks.comZAK - Paid Partner Content |
| The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far) Jun 26 / MotleyFool.comFOO - Paid Partner Content | Bristol-Myers to Sell Otezla for Celgene Merger, Shares Down Jun 25 / Zacks.comZAK - Paid Partner Content |
| AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal Jun 26 / Zacks.comZAK - Paid Partner Content | The 10 Biggest Biotech Stocks Jun 25 / MotleyFool.comFOO - Paid Partner Content |
| AbbVie to Buy Allergan: Prescribed ETFs Jun 26 / Zacks.comZAK - Paid Partner Content | Company News For Jun 25, 2019 Jun 25 / Zacks.comZAK - Paid Partner Content |
| Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know Jun 25 / Zacks.comZAK - Paid Partner Content | What Happened in the Stock Market Today Jun 24 / MotleyFool.comFOO - Paid Partner Content |
| Previous close | 45.77 |
| Today’s open | 45.86 |
| Day’s range | 44.54 - 45.98 |
| Volume | 21,924,218 |
| Average volume (3 months) | 16,914,409 |
| Market cap | $80.7B |
| Earnings growth (last year) | +393.92% |
| Earnings growth (this year) | +5.56% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 14.3 |
| Price/Sales | 3.77 |
| Price/Book | 5.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene | -0.78 | -0.84% |
| TAKTakeda Pharmaceutica... | +0.10 | +0.57% |
| NVONovo Nordisk | -0.27 | -0.53% |
| ZTSZoetis Inc | -0.81 | -0.71% |
| Next reporting date | July 25, 2019 |
| EPS forecast (this quarter) | $1.06 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
